The AACI CRI Steering Committee is currently soliciting abstracts for the 13th Annual AACI CRI Meeting. This year’s meeting theme will focus on adapting cancer clinical research for 2021 and beyond. The purpose of the abstracts is to inform meeting attendees about clinical trials office challenges and solutions implemented at AACI cancer centers.
Three abstracts will be selected for oral presentation at the meeting. Up to two authors of each winning abstract will receive a complimentary meeting registration. While AACI encourages collaboration with external organizations, only employees of AACI member cancer centers are eligible for complimentary meeting registration. Additionally, AACI will recognize seven abstracts, one from each abstract category, to be presented at an honorable mention session.
Information about the 2021 poster session is forthcoming.
The abstract's first author must be from an AACI cancer center. Members from more than one center or organization may collaborate. For all authors, please list full first and last names with credentials. If the first author and co-author(s) are from different institutions or organizations, please indicate each investigator's institution using a superscript number, as in the example below:
Rachel Jones, MD1; Jill Smith, PhD2; Brandon Lee, MPH3
1Cancer Center A; 2Cancer Center B; 3Cancer Center C
You must use the AACI CRI abstract template as a guideline to draft your submission. The abstract word limit is 500 words, not including the abstract title, author and institution names, and abstract template section titles. The online submission tool will open in February using the same section headers. AACI is providing access to its institutional style guide to help authors standardize the format of all abstracts to simplify their review and publication in CRI's book of abstracts and posters.
Authors will submit abstracts to a specific category. Please select the category that is the best fit for your abstract:
Regulatory
Training, Quality Assurance, Remote Monitoring and Auditing
Finance/CCSG/PRMS
Trial Recruitment & Community Outreach and Engagement
Trial Start-up
Clinical Operations
Investigator-Initiated Trials
Note: If a reviewer believes your abstract is better suited for a different category, they may edit this selection.
You may include one graphic element (photogaph, illustration, table, or graph, no larger than 4"x6") as an attachment. Please make sure to upload your graphic element as a jpeg file.
All submitted abstracts should be ready for publication. You may submit your abstract using the online submission tool beginning in February. If you have any questions, please contact cri@aaci-cancer.org.
The abstract deadline is 5:00 pm Pacific time on Monday, March 15, 2021.
Why should I submit an abstract?
An abstract tells a story about how your center has addressed a clinical trials operational problem. Since many AACI cancer centers face similar obstacles, sharing your story helps promote practices leading to better efficiency and quality at other AACI cancer centers.
Who can submit an abstract?
AACI members may collaborate with other centers or external organizations to submit an abstract.
What should I include in my abstract?
You must use the provided abstract template and describe the following:
Do I have to use the AACI CRI abstract template?
It is highly recommended authors use the AACI CRI abstract template, as the template requires the same information that will be collected in the online submission tool. We also recommend using the AACI style guide to ensure consistency in punctuation and formatting.
May I submit an abstract presented at a past meeting?
Yes. However, if the abstract was submitted for a prior AACI CRI Annual Meeting, the abstract must be significantly updated from the initial submission. Changes may include project expansion, new or updated results, and/or completion of next steps.
Can I submit an abstract with research that is in progress/interim analysis?
Yes, as with all abstracts, a description of data analysis helps to support your conclusions. If you are providing an abstract where the data analysis is not available but other findings can support your solutions and/or lessons learned, the committee is interested in reviewing those abstracts as well.
How do I submit my abstract?
Beginning in February, authors will be able to enter information online using AACI's online submission tool.
Can I make changes to a submitted abstract?
You will be able to edit your abstract in the submission tool until the abstract deadline on March 15 at 5:00 pm Pacific time. You will not be able to make changes after the deadline.
Are examples of other CRI meeting abstracts available for review?
Yes. You may view abstracts and posters from the 12th Annual AACI CRI Meeting in the 2020 Abstract and Posters Book.
How are abstracts scored and selected for presentation?
Abstracts are evaluated by at least two reviewers from the AACI CRI community using a peer-review process. Final selections are made by the AACI CRI Steering Committee. Three abstracts will be chosen for oral presentation that address an issue that provides relevant solutions that can be shared or adapted by other AACI cancer centers. Additionally, AACI will recognize seven abstracts, one from each abstract category, to be presented at an honorable mention session.
When will applicants be notified of their review outcome?
Abstract applicants will be notified in May 2021.
What is the size requirement for the poster?
Posters may not exceed 24” x 36” (portrait) or 36” x 24” (landscape).
What is a digital presentation?
In addition to submitting a poster, all authors are invited to submit a brief, pre-recorded digital presentation. Digital presentations are brief audio presentations via PowerPoint describing your poster and will be featured on the meeting app. Digital presentations are not required, but can be submitted in place of or in addition to a poster.
What format or program should I use to develop my poster and/or digital presentation?
You may format your poster using a program of your choice. PowerPoint templates are available in landscape and portrait format.
Do I need to submit an electronic copy of my poster and/or digital presentation?
Attendees enjoy viewing posters prior to the meeting. Your poster and/or digital presentation must be emailed to mail@aaci-cancer.org by 5:00 pm Pacific time on Monday, May 17, 2021 for it to be displayed during the meeting. Please email a full-sized, 24” x 36” (portrait) or 36” x 24” (landscape) version of your poster and/or an mp4 video of your digital presentation.
Does AACI CRI require a hard copy of my poster?
A hard copy is not required.
How will posters be displayed?
Information regarding the poster session is forthcoming.
What happens to my abstract after the meeting?
Abstracts and posters are published in a booklet that will be published online and distributed at the 2021 AACI/CCAF Annual Meeting, which is attended by cancer center directors, administrators, and physician clinical leaders. By submitting an abstract and poster, you give AACI permission to publish these materials. Your abstract will also be available for review on the AACI CRI abstracts and posters webpage for up to one year or until the next AACI CRI Annual Meeting.
Please refer to the AACI Style Guide for punctuation and formatting guidance when preparing your abstract.